208 related articles for article (PubMed ID: 19360918)
1. Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma.
Wu YH; Cao JG; Xiang HL; Xia H; Qin Y; Huang AJ; Xiao D; Xu F
World J Gastroenterol; 2009 Apr; 15(14):1744-50. PubMed ID: 19360918
[TBL] [Abstract][Full Text] [Related]
2. Vascular basement membrane-derived multifunctional peptide, a novel inhibitor of angiogenesis and tumor growth.
Cao JG; Peng SP; Sun L; Li H; Wang L; Deng HW
Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):514-21. PubMed ID: 16820868
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
4. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
5. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
6. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
Xiong YQ; Sun HC; Zhu XD; Zhang W; Zhuang PY; Zhang JB; Xu HX; Kong LQ; Wu WZ; Qin LX; Tang ZY
J Cancer Res Clin Oncol; 2011 Mar; 137(3):505-12. PubMed ID: 20490863
[TBL] [Abstract][Full Text] [Related]
8. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
Zhu XD; Zhang JB; Fan PL; Xiong YQ; Zhuang PY; Zhang W; Xu HX; Gao DM; Kong LQ; Wang L; Wu WZ; Tang ZY; Ding H; Sun HC
BMC Cancer; 2011 Jan; 11():28. PubMed ID: 21251271
[TBL] [Abstract][Full Text] [Related]
10. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
[TBL] [Abstract][Full Text] [Related]
11. Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.
Qiu YQ; Zhou J; Kang XS; Ding LM; Yu W; Tan FL; Deng DF
Sci Rep; 2014 Mar; 4():4324. PubMed ID: 24632756
[TBL] [Abstract][Full Text] [Related]
12. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of iressa on hepatocellular carcinoma Hep-3B and HepG2 cell xenografts in nude mice].
Xu L; Zhang YJ; Lin XJ; Li JQ
Ai Zheng; 2006 Apr; 25(4):447-50. PubMed ID: 16613678
[TBL] [Abstract][Full Text] [Related]
14. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
15. [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice].
Chen S; Xie Y; Wang CH; Tang CW
Ai Zheng; 2009 Jul; 28(7):673-8. PubMed ID: 19624890
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
[TBL] [Abstract][Full Text] [Related]
17. Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
Shen FZ; Wang J; Liang J; Mu K; Hou JY; Wang YT
Int J Exp Pathol; 2010 Feb; 91(1):10-6. PubMed ID: 20096070
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
Liu L; Qin S; Zheng Y; Han L; Zhang M; Luo N; Liu Z; Gu N; Gu X; Yin X
Cancer Biol Ther; 2017 Mar; 18(3):166-176. PubMed ID: 28368741
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma.
Yan M; Dongmei B; Jingjing Z; Xiaobao J; Jie W; Yan W; Jiayong Z
Sci Rep; 2017 Oct; 7(1):14074. PubMed ID: 29075040
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vascular basement membrane derived multifunctional peptide blocks endothelial cell angiogenesis and neovascularization.
Wang C; Cao J; Qu J; Li Y; Peng B; Gu Y; He Z
J Cell Biochem; 2010 Oct; 111(2):453-60. PubMed ID: 20524205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]